Suppr超能文献

红花多糖的提取、结构、生物活性及结构-功能分析

Extraction, Structures, Bioactivities and Structure-Function Analysis of the Polysaccharides From Safflower ( L.).

作者信息

Wu Xiaoyi, Cai Xinbo, Ai Jiaxuan, Zhang Chi, Liu Nan, Gao Wei

机构信息

School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.

Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

出版信息

Front Pharmacol. 2021 Oct 20;12:767947. doi: 10.3389/fphar.2021.767947. eCollection 2021.

Abstract

Safflower ( L.) is a herbal plant with a long history of clinical application worldwide, such as coronary heart disease, hypertension, dysmenorrhea and amenorrhea. It is also extensively used as an important oilseed plant for hundreds of years in some countries, like China, India, Mexico and the United States. Therefore, safflower is believed as a crop with dual values of medicine and economy as well. Safflower polysaccharides (SPS), from the plant, are believed as one of the most important biologically active components with multiple pharmacological properties, including anti-tumor, immune regulation, anti-oxidation, and anti-cerebral ischemia reperfusion injury effects. The polysaccharides, from bee pollen of safflower, named PBPC, also attract the attention of researchers because of their particular origin and bioactivities. Although the extraction, purification, structure and biological activities of SPS and PBPC have been studied for decades, there is not any available review both concerning SPS and PBPC. In this condition, this paper aims to systematically review the research progress in extraction, purification, structural characteristics, and bioactivities of SPS and PBPC, and provide basis for the in-depth study about their structure-bioactivity relationship. It will serve as a methodological outline for further research in fields of new drug discovery and clinical application of SPS or PBPC, and simultaneously remind us of unresolved problems noted in the polysaccharide research.

摘要

红花(Carthamus tinctorius L.)是一种在全球范围内有着悠久临床应用历史的草本植物,可用于治疗冠心病、高血压、痛经和闭经等病症。在一些国家,如中国、印度、墨西哥和美国,它还作为重要的油料作物被广泛种植了数百年。因此,红花被认为是一种具有药用和经济双重价值的作物。红花多糖(SPS)是该植物中最重要的生物活性成分之一,具有多种药理特性,包括抗肿瘤、免疫调节、抗氧化和抗脑缺血再灌注损伤等作用。来源于红花蜂花粉的多糖,称为PBPC,因其独特的来源和生物活性也引起了研究人员的关注。尽管对SPS和PBPC的提取、纯化、结构和生物活性已经研究了数十年,但尚未有关于SPS和PBPC的综合综述。在此情况下,本文旨在系统地综述SPS和PBPC在提取、纯化、结构特征和生物活性方面的研究进展,为深入研究它们的构效关系提供依据。它将为SPS或PBPC在新药发现和临床应用领域的进一步研究提供方法概述,同时提醒我们多糖研究中尚未解决的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0dd/8563581/0d3e9a63b4c2/fphar-12-767947-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验